"As one of the most advanced eye clinics in the country, Vold Vision is honored to serve patients in our 3 clinics located across the Northwest Arkansas region. Patients have traveled from 40 states and 10 countries to receive vision treatments from the Vold Vision team. Led by Dr. Steven Vold, our team of 8 doctors provides personalized care for each patient that walks through our doors. We treat patients for a variety of visual goals and concerns, from general eye exams to LASIK or glaucoma care. Our comprehensive eye center houses an FDA certified research facility, Joint Commission certified surgery center, and optical department. Proud to be the "Official Eye Care Provider for the Arkansas Razorbacks and NWA Naturals""

During the past decade, Vold Vision conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 7 clinical trials were completed, i.e. on average, 53.8% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 5 clinical trials were completed. i.e. 71.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Vold Vision" #1 sponsor was "AqueSys, Inc." with 2 trials, followed by "ForSight Vision5, Inc." with 2 trials sponsored, "InnFocus Inc." with 2 trials sponsored, "Sight Sciences, Inc." with 2 trials sponsored and "Vold Vision P.L.L.C" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Vold Vision" #1 collaborator was "Alcon Research" with 2 trials as a collaborator and "Allergan" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Vold Vision" are "Glaucoma, Open-Angle" (6 trials), "Cataract" (4 trials), "Glaucoma" (4 trials), "Ocular Hypertension" (4 trials) and "Primary Open-Angle Glaucoma" (2 trials). Many other conditions were trialed in "Vold Vision" in a lesser frequency.

Most popular intervention types in "Vold Vision" are "Device" (11 trials), "Drug" (4 trials), "Procedure" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bimatoprost" (2 trials), "Active Comparator: Timolol 0.5%" (1 trials), "AqueSys Microfistula Implant" (1 trials), "AqueSys XEN 45 Glaucoma Implant" (1 trials) and "Bimatoprost SR" (1 trials). Other intervention names were less common.

The vast majority of trials in "Vold Vision" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Vold Vision". 1 are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Vold Vision, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Vold Vision, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 9 trials that are defined as “Not Applicable".